Sunday, May 17, 2020

Sree Rayalaseema Hi-Strength Hypo Ltd - Valuation Update


Sree Rayalaseema Hi-Strength Hypo Ltd closes   at  97.80   with  a  Loss     of   -0.60 %   on    15-May- 2020   with formation of  a  Small Red  Candle    on Daily  Price Chart.
The company has posted Net Sales of Rs.706 Cr and Net Profit of Rs.9.00 Cr during the past 4Quaters ( March-Dec 2019).
At CMP  it’s trading  at X 1.2 of its Valuations ( ~20 Premium ) with   Margin of Safety (1Yr Bond Yield: Value>1 ) 1.30. Its Growth Candidate ( If >1 ) is 1.03, which makes it Attractive.
Disclaimer : We are / may going to take exposure shortly.
Join Us at   Telegram #   https://t.me/TheNiftyNext
Data Source | NSE Website | Screener.In  | Capital Line | Money Control | SMC Global |
The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |


Kaveri Seed Company Ltd - Valuation Update & Price Tag


Kaveri Seed Company Ltd closes   at  376.45   with  a  Gain     of   +1.60 %   on    15-May- 2020   with formation of  a  Small Green  Candle    on Daily  Price Chart.
The company is expected to post  Revenue of Rs.885.90 Cr & Net Profit of Rs.242.70Cr (Last Year  Revenue of Rs.809.40 Cr & Net Profit of Rs.217.4 Cr  FY2019)  in FY2020 and Revenue of Rs.718.60 Cr & Net Profit of Rs.160.70 Cr in FY2021;  Revenue of Rs.913.80 Cr & Net Profit of Rs.252.90 Cr in FY2022 and Revenue of Rs.960.20 Cr & Net Profit of Rs.264.00 Cr in FY2023.
At CMP  it’s trading with   Margin of Safety (1Yr Bond Yield: Value>1 ) of 2.70.
Valuations  : The Company is now Trading at X0.6 of its Value ( last 4 Quarters earnings considered ) . We have valued the company with its full  Financial  year 2020 earnings  ( PAT ), which is now X0.57, a  Discount  of ~43 % to its Value ( EPV Method ) and X0.86 of its FY21 earnings with a Discount of ~14% ; X0.55 of its FY22 earnings with a Discount of ~45% and X0.52  of its FY23 earnings with a Discount of ~48%
Disclaimer : We are / may going to take exposure shortly.
Join Us at   Telegram #   https://t.me/TheNiftyNext
Data Source | NSE Website | Screener.In  | Capital Line | Money Control | SMC Global |
The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Sunday, May 10, 2020

Ipca Laboratories Ltd - Valuation Update & Price Movement


Ipca Laboratories Ltd  closes   at  1531.90  with  a  Gain     of    +0.2 %   on    08-May- 2020   with formation of  a  Green  Candle    on Daily  Price Chart.
The company is expected to post  Revenue of Rs.4472.45 cr & Net Profit of Rs.656.68 Cr (Last Year  Revenue of Rs.3773.18 Cr & Net Profit of Rs.444.83 Cr  FY2019)  in FY2020 and Revenue of Rs.5093.11 cr & Net Profit of Rs.787.77Cr in FY2021.
At CMP  it is  at Premium  in EV/EBITDA to 10 Yrs Avg by ~33%
Valuations  : The Company is now Trading at X2.8 of its Value ( last 4 Quarters earnings considered )  .We have valued the company with its full  Current year 2020 earnings  ( PAT ), which is now X2.07, a  premium  of ~207% to its Value ( EPV Method ) and X1.49 of its CY21 earnings with a Premium of ~49% to its Value.
Disclaimer : We are / may going to take exposure shortly.
Join Us at   Telegram #   https://t.me/TheNiftyNext
Data Source | NSE Website | Screener.In  | Capital Line | Money Control | SMC Global |
The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Disclaimer

The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. www.niftynext..com does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.


Blog Archive